Keyphrases
CD8+ T Cells
89%
Programmed Death-ligand 1 (PD-L1)
74%
Dendritic Cells
71%
T Cells
45%
Tumor
38%
Hepatocellular Carcinoma
29%
Exhausted CD8 T Cells
26%
Chronic Viral Infection
26%
Ovalbumin
26%
T Cell Response
20%
Chronic Infection
20%
T Cell Exhaustion
19%
PD-1 Blockade
19%
B Cells
18%
Peripheral Blood
17%
Targeted Therapy
17%
Germinal Center
17%
Immune Response
17%
Chronic Cancer
16%
CD28
16%
Stem Cells
16%
CD4 T Cells
15%
MHC Class II
15%
Zinc Finger Transcription Factor
14%
Antibody Effector Function
14%
Virus-associated Cancer
14%
Oral Tolerance
14%
Persistent Viral Infection
14%
Lymphocytic Choriomeningitis Virus Infection
14%
Non-small Cell Lung Cancer (NSCLC)
14%
Immune Checkpoint Inhibitors
13%
Antigen Presentation
13%
Steady State
13%
Macrophages
12%
Infected Mice
11%
Lymphocytic Choriomeningitis Virus
11%
CD8+ T Cell Response
11%
Regulatory T Cells
11%
Lung Cancer
11%
T Cell Differentiation
11%
Latently Infected
11%
CD8+
11%
Chronic Lymphocytic
10%
T Cell Help
9%
Humoral Response
9%
Cancer Patients
9%
T Helper Cells
9%
Response to Immunotherapy
9%
CD-8
9%
In Cancer
9%
Immunology and Microbiology
Cytotoxic T-Cell
100%
T Cell
96%
Dendritic Cell
74%
Viral Disease
47%
Immunology
39%
Immunotherapy
33%
Programmed Cell Death 1
30%
Immunity
28%
T-Helper Cell
22%
Immune Response
22%
Antigen Presentation
20%
B Cell
19%
Immunocompetent Cell
18%
Lymphocytic Choriomeningitis Virus
18%
CD8
18%
Germinal Center
16%
CD28
16%
Transcription Factors
15%
Cell Lineage
14%
Macrophage
14%
Precursor
13%
Humoral Immunity
13%
Major Histocompatibility Complex
12%
Regulatory T Cell
12%
CD4
12%
Maturation
11%
T Helper Cell
11%
T Cell Receptor
11%
Cell Activation
11%
interferon
10%
Cell Differentiation
10%
Myeloid
9%
Gene Expression
9%
Steady State
9%
Antigen Specificity
9%
Dynamics
9%
Adoptive Immunity
9%
Natural Killer Cell
9%
Genetic Selection
9%
Cytokine
9%
Dendritic Cell Subset
8%
Adjuvant
8%
Mouse Model
8%
CD11c
8%
Antigen
7%
Antigenicity
7%
Cross-Presentation
7%
Cancer Associated Fibroblast
7%
Transcription Factor 7
7%
Plasmodium
7%
Medicine and Dentistry
Cytotoxic T-Cell
41%
Lung Cancer
30%
Malignant Neoplasm
24%
T Cell
23%
Programmed Cell Death
22%
Neoplasm
18%
Infection
17%
Targeted Therapy
16%
Immune Checkpoint Inhibitor
9%
Programmed Death 1 Ligand 1
9%
Immunity
9%
Immunosuppressive Treatment
8%
Triggering Receptor Expressed on Myeloid Cells 2
7%
Transcription Factor 7
7%
Gene Expression
7%
Natural Killer Cell
7%
Immunology
7%
Cardiac Graft Rejection
7%
Bladder Cancer
7%
Cemiplimab
7%
COVID-19
7%
Severe Acute Respiratory Syndrome Coronavirus 2
7%
Cancer Immunotherapy
7%
Arm
7%
Hepatocellular Carcinoma
7%
Cancer Associated Fibroblast
7%
Macrophage
7%
Human Leukocyte Antigen
7%
Melanoma
7%
Lymphocyte
7%
Immunostimulation
6%
Immunotherapy
5%
T-Cell Response
5%
Adverse Event
5%